EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling
This article was originally published in The Rose Sheet
EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.
You may also be interested in...
Notification may come within weeks for the 49th Amendment to the International Fragrance Association’s Code of Practice, which will update safe use standards for fragrance materials based on a revised quantitative risk assessment framework that uses a new aggregate exposure model for dermal sensitizers, among other changes. IFRA has been working closely on the issue of fragrance allergens with the European Commission.
The Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2019 has cleared key Senate committees, including Appropriations, and is now up for a third read on the Senate floor.
Clarification of requirements and a “demanding” timeline for industry’s defense of cosmetic ingredients identified as potentially carcinogenic, mutagenic or reprotoxic, and the Commission’s forthcoming list of potential endocrine disruptors in cosmetic products, are among challenges facing Cosmetics Europe in 2019 and beyond.